108 related articles for article (PubMed ID: 10755865)
1. [Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C].
Winkfield B; Lunel F; Beurrier P; Calès P
Gastroenterol Clin Biol; 2000 Jan; 24(1):136-7. PubMed ID: 10755865
[No Abstract] [Full Text] [Related]
2. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
3. [Disappearance of serum autoantibodies during treatment with interferon alpha in a patient with chronic hepatitis C].
Khemissa F; Bauget P; Michel H; Larrey D
Gastroenterol Clin Biol; 1997; 21(12):998-9. PubMed ID: 9587568
[No Abstract] [Full Text] [Related]
4. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
Hamidah A; Yong JF; Zulkifli HI; Jamal R
Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
[TBL] [Abstract][Full Text] [Related]
5. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
6. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C treatment with amantadine-HCL in non-responders to alpha-interferon].
Smith JP
Arq Gastroenterol; 1999; 36(2):61-2. PubMed ID: 10511882
[No Abstract] [Full Text] [Related]
8. Host factors and failure of interferon-alpha treatment in hepatitis C virus.
Gao B; Hong F; Radaeva S
Hepatology; 2004 Apr; 39(4):880-90. PubMed ID: 15057887
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C.
Hokari A; Zeniya M; Esumi H; Ishikawa T; Kurasima Y; Toda G
J Infect; 2005 Jul; 51(1):47-53. PubMed ID: 15979491
[TBL] [Abstract][Full Text] [Related]
10. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
[TBL] [Abstract][Full Text] [Related]
11. [alpha-Interferon therapy in chronic hepatitis C evaluated].
Internist (Berl); 1996 Jul; 37(7 Suppl Alpha-inte):1-4. PubMed ID: 9541670
[No Abstract] [Full Text] [Related]
12. [Treatment of hepatitis C--update 2005].
Forestier N; Zeuzem S
Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S215-6. PubMed ID: 16435713
[No Abstract] [Full Text] [Related]
13. Treatment of hepatitis C virus: the first decade.
Poynard T
Semin Liver Dis; 2004; 24 Suppl 2():19-24. PubMed ID: 15346242
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy.
Hamamoto S; Uchida Y; Wada T; Moritani M; Sato S; Hamamoto N; Ishihara S; Watanabe M; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):204-8. PubMed ID: 15683422
[TBL] [Abstract][Full Text] [Related]
15. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
[TBL] [Abstract][Full Text] [Related]
16. Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.
Hino K; Okita K
J Antimicrob Chemother; 2004 Jan; 53(1):19-22. PubMed ID: 14657083
[TBL] [Abstract][Full Text] [Related]
17. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-alpha and/or ribavirin.
Di Martino V; Boudjema H; Delacour T; Cazier A; Caron C; Coutarel P; Dumouchel P; Cadranel JF
Clin Infect Dis; 2001 Mar; 32(5):830-1. PubMed ID: 11229855
[TBL] [Abstract][Full Text] [Related]
20. [Serum intercellular adhesion molecule ICAM-1 concentration in interferon alpha treated patients with chronic viral C hepatitis].
Warakomska I; Wiczkowski A; Kepa L; Stolarz W; Wilczek K; Błedowski D; Sobala-Szczygieł B; Oczko-Grzesik B; Dziambor AP; Mossor K
Wiad Lek; 2004; 57(11-12):641-6. PubMed ID: 15865242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
